Fucoidan induces apoptosis and inhibits proliferation of hepatocellular carcinoma.

PMID:  Cancer Manag Res. 2020 ;12:1713-1723. Epub 2020 Mar 9. PMID: 32210612 Abstract Title:  Fucoidan Induces Apoptosis and Inhibits Proliferation of Hepatocellular Carcinoma via the p38 MAPK/ERK and PI3K/Akt Signal Pathways. Abstract:  Purpose: Fucoidan is a natural bioactive product with broad therapeutic applications. Hepatocellular carcinoma (HCC) is a common malignancy of the liver associated with …

Fucoidan induces apoptosis of HT-29 cells.

PMID:  Mar Drugs. 2020 Apr 20 ;18(4). Epub 2020 Apr 20. PMID: 32326052 Abstract Title:  Fucoidan Induces Apoptosis of HT-29 Cells via the Activation of DR4 and Mitochondrial Pathway. Abstract:  Fucoidan has a variety of pharmacological activities, but the understanding of the mechanism of fucoidan-induced apoptosis of colorectal cancer cells remains limited. The results of …

Shikonin suppresses NEAT1 and Akt signaling in treating paclitaxel-resistant non-small cell of lung cancer.

PMID:  Mol Med. 2020 Apr 8 ;26(1):28. Epub 2020 Apr 8. PMID: 32268876 Abstract Title:  Shikonin suppresses NEAT1 and Akt signaling in treating paclitaxel-resistant non-small cell of lung cancer. Abstract:  BACKGROUND: The development of paclitaxel-resistance led to the tumor relapse and treatment failure of non-small cell lung cancer. Shikonin has been demonstrated to show anti-cancer …

Shikonin is a promising candidate for treatment of postmenopausal osteoporosis.

PMID:  Biomed Pharmacother. 2020 Jun ;126:110067. Epub 2020 Apr 6. PMID: 32272431 Abstract Title:  Shikonin mitigates ovariectomy-induced bone loss and RANKL-induced osteoclastogenesis via TRAF6-mediated signaling pathways. Abstract:  BACKGROUND: Postmenopausal osteoporosis results from estrogen withdrawal and is characterized mainly by bone resorption. Shikonin is a bioactive constitute of Chinese traditional herb which plays a role in …

Shikonin could be a promising antioxidant candidate for age-associated neurodegenerative diseases.

PMID:  Int Immunopharmacol. 2020 Apr 9 ;83:106491. Epub 2020 Apr 9. PMID: 32279045 Abstract Title:  Shikonin ameliorates D-galactose-induced oxidative stress and cognitive impairment in mice via the MAPK and nuclear factor-κB signaling pathway. Abstract:  Oxidative stress acts as the major causative factor for various age-associated neurodegenerative diseases, triggering cognitive and memory impairments. In the present …

Shikonin inhibits growth, invasion and glycolysis of nasopharyngeal carcinoma cells.

PMID:  Anticancer Drugs. 2020 Apr 8. Epub 2020 Apr 8. PMID: 32282369 Abstract Title:  Shikonin inhibits growth, invasion and glycolysis of nasopharyngeal carcinoma cells through inactivating the phosphatidylinositol 3 kinase/AKT signal pathway. Abstract:  Nasopharyngeal carcinoma (NPC) is a malignant tumor which is commonly found in East Asia and Africa. The present clinical treatment of NPC …

Shikonin attenuated a high fat diet-induced nonalcoholic fatty liver disease.

PMID:  Nutrients. 2020 Apr 17 ;12(4). Epub 2020 Apr 17. PMID: 32316687 Abstract Title:  Shikonin Attenuates Hepatic Steatosis by Enhancing Beta Oxidation and Energy Expenditure via AMPK Activation. Abstract:  Shikonin, a natural plant pigment, is known to have anti-obesity activity and to improve insulin sensitivity. This study aimed to examine the effect of shikonin on …

Curcumin reduces lung inflammation via Wnt/β-catenin signaling in mouse model of asthma.

PMID:  J Asthma. 2017 May ;54(4):335-340. Epub 2016 Aug 15. PMID: 27715343 Abstract Title:  Curcumin reduces lung inflammation via Wnt/β-catenin signaling in mouse model of asthma. Abstract:  OBJECTIVES: Asthma is a chronic inflammatory, heterogeneous airway disease affecting millions of people around the world. Curcumin has been found to have anti-inflammatory and antifibrosis effects. Researchers reported …

Design a site like this with WordPress.com
Get started